# Varex Imaging Corporation (VREX) Stock Analysis: A 44% Upside Potential Amid Medical Device Market Growth

- Link: https://www.directorstalkinterviews.com/varex-imaging-corporation-vrex-stock-analysis-a-44-upside-potential-amid-medical-device-market-growth/4121231159
- Published: 2025-12-18T11:11:19+00:00
- Author: Madison Wilson

Investors eyeing opportunities in the healthcare sector should take a closer look
at Varex Imaging Corporation (NASDAQ: VREX), a key player in the medical devices
industry with a notable potential upside of 44.42%. With its current market capitalization
at approximately $496.52 million, Varex Imaging is a company that designs and manufactures
a wide array of X-ray imaging components, serving both medical and industrial segments
across the globe.

**A Snapshot of Varex Imaging’s Market Position**

Headquartered in Salt Lake City, Utah, Varex Imaging operates in diverse regions
including North America, Latin America, Europe, and Asia. The company’s medical 
segment is instrumental in developing crucial X-ray components and software for 
applications ranging from CT scans and mammography to oncology and cardiac imaging.
The industrial segment, on the other hand, focuses on security and inspection systems
used in critical infrastructure protection, like airport baggage and cargo screening.

**Financial Metrics and Valuation Insights**

Currently trading at $11.91, Varex Imaging’s stock has experienced a 52-week range
from $6.88 to $15.20, reflecting its volatility but also potential for recovery 
and growth. Despite the absence of a trailing P/E ratio and a PEG ratio, the forward
P/E stands at a relatively attractive 12.37, suggesting investor confidence in future
earnings growth.

The company has shown commendable revenue growth of 11.30%, although its EPS is 
reported at -1.70, indicating a net loss. Additionally, a negative return on equity
of -13.58% highlights areas for potential improvement in financial performance. 
However, the positive free cash flow of approximately $39.5 million demonstrates
the company’s ability to generate cash, which can be reinvested into operations 
or used to service debt.

**Investor Sentiment and Analyst Ratings**

Analysts have a favorable outlook on Varex Imaging, with four buy ratings and one
hold rating. The average target price is set at $17.20, suggesting a significant
potential upside from the current price. The consensus target price range spans 
from $12.00 to an optimistic $22.00, signaling varied expectations about the company’s
growth trajectory.

**Technical Indicators and Market Momentum**

From a technical standpoint, Varex Imaging’s stock is currently trading above its
50-day moving average of $11.63 and significantly above its 200-day moving average
of $10.09. The Relative Strength Index (RSI) at 38.03 suggests the stock is approaching
oversold territory, which could present a buying opportunity for investors seeking
value.

**Strategic Considerations for Investors**

For investors, Varex Imaging represents an intriguing blend of risk and potential
reward. The company’s robust presence in both medical and industrial sectors positions
it well to capitalize on growing demand for advanced imaging solutions. Additionally,
the significant potential upside indicated by analyst targets, in conjunction with
strategic investments in product innovation and market expansion, could drive future
profitability.

With a diversified product portfolio and a strong global footprint, Varex Imaging
is well-positioned to navigate the challenges and opportunities of the healthcare
and security sectors. Investors considering an entry in the medical devices industry
may find Varex Imaging an attractive option to explore, particularly given its current
valuation metrics and market potential.

Share on:
